Page 649 - e-Book
P. 649

cheaper health care products and new plant-based therapeutic markets in preference to more

               expensive target-specific drugs and biopharmaceuticals
               Orchids have been described as the “Royal Family” of plants by those captivated by their

               exquisite flowers of myriad shapes, sizes, and colours. The Chinese were the first to cultivate
               and describe orchids  for medicinal use. Confucius (551-479 BC), the Chinese philosopher

               called  the  orchid  (lan  in  Chinese)  the  “King  of  Fragrant  Plants”.  The  Greeks  referred  to
               testicles as orchis,and Theophrastus (370-287 BC) named the orchids from that word, as the

               underground tubers of many European terrestrial orchids resemble a pair of testicles.He made

               mention  about  the  medicinal  properties  of  orchids  in  his  book  “Enquiry  into
               Plants”.Dioscorides  (0040-0090  AD),a  Greek  botanist,  physician  and  pharmacologist

               mentioned orchids in his work “De Materia Medica”.He adopted and promoted the popular

               theory  “The  Doctrine  of  Signatures”  and  commented  on  the  usefulness  of  orchids  as  a
               determinant of the sex of the offspring .He believed that ingestion of dried tubers by woman

               give  female  progeny  while  the  ingestion  of  fresh  tubers  by  man  would  produce  male
               offspring(Bulpitt,2005). The first reference to orchids in the western hemisphere appears in

               1532 in the “The Badianus MS” an Aztec herbal. The first record of orchids in cultivation
               dates back to 1731 in England. Records of Kew Botanical Gardens show that Epidendrum

               cochleatum flowered for the first time in cultivation in 1787.In India the earliest mention of

               Orchids is found in Charaka Samhita (A.D.100), which describes the medicinal properties of
               ‘Vanda’.

               Their numerical strength in terms of species has been variously estimated [(17,000-35,000;
               Dressler,  1993),  (19,128  sp.;  Atwood,  1986),  (18,000sp.750  genera;  Heywood,  1993),

               (19,500 sp. 775 genera; Judd et al., 1999), (20,000sp. Lawler & Rao, 2002)].The orchids are
               cosmopolitan in distribution except in Antarctica. Ground habit is basic in these plants but

               their major speciation has revolved around the epiphytic mode. Their habit is diverse varying

               from terrestrial to epiphytic and lithophytes to subterranean. They are myco-heterotrophic or
               autotrophic  but  they  are  never  parasitic.  The  orchids  are  inherently  slow  growers,  have

               fascinating floral morphology, and highly advanced reproductive biology.

               Besides contributing tremendously to the growth and development of international trade in
               floriculture, the orchids are also therapeutically significant. The ancient literature is replete

               with their utility in traditional drug formulations (cf. Lawler, 1984). Many of them continue
               to  be  used  to  cure  a  variety  of  ailments  including  those  related  to  nervous  (Cymbidium

               elegans,  Cypripedium  pubescens,  Epipactis  latifolia),  rheumatic  (Acampe  papillosa,  A.
               praemorsa, Rhynchostylis retusa, Vanda testacea), dermal (Dendrobium alpestre, Eulophia




                                                           639
   644   645   646   647   648   649   650   651   652   653   654